Gene · 79026
AHNAK: AHNAK nucleoprotein
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. AHNAK: AHNAK nucleoprotein. Genes, record 79026. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/79026
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q09666 | Neuroblast differentiation-associated protein AHNAK | 5,890 | 3 | Ensembl, GeneID, HGNC |
Source UniProt
Patents60
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 9995 | Q09666 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 1512 | Q09666 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 10271 | Q09666 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 5697 | Q09666 | Espacenet |
| JP 2025519096 A | 2025-06-24 | 1512 | Q09666 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 10271 | Q09666 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 9995 | Q09666 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 3659 | Q09666 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 24307 | Q09666 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 5697 | Q09666 | Espacenet |
1 to 10 of 60
See all 60 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,117
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | AHNAK papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 8 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 3 | 2025 |
| P30AG072975 | Rush Alzheimer's Disease Research Center | 2 | 2025 |
| P30CA006516 | Dana-Farber/Harvard Cancer Center | 2 | 2025 |
| P30CA014051 | Cancer Center Support (Core) Grant | 2 | 2025 |
| P30CA014089 | University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG) | 2 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 2 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 2 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 1,117Source NIH's project files
See all 1,117 nih grantsPapers1,483
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AHNAK context-dependently regulates breast cancer cell mechanics, endothelial adhesion, and survival under fluid shear stress. | Biochem Biophys Res Commun | 2026 | 42772180 | PubTator, text mining | PubMed |
| Targeting AHNAK ameliorates osteonecrosis of the femoral head and affects adipogenic pathways involving Smad/PPARγ. | Bone Joint Res | 2026 | 42613017 | PubTator, text mining | PubMed |
| Investigation and validation of prognostic features associated with transient receptor potential channel genes in gastric cancer. | PeerJ | 2026 | 42602890 | PubTator, text mining | PubMed |
| Childhood Adversity and Cardiovascular Disease Risk: Unraveling Plasma Proteomic Pathways and Moderating Role of Genetic Predisposition. | J Am Heart Assoc | 2026 | 42500902 | PubTator, text mining | PubMed |
| Multi-omics Mendelian randomization integrating metabolism, microbiome and immunity supports a putative gut-immune-pelvic pathway in deep infiltrating endometriosis. | Front Endocrinol (Lausanne) | 2026 | 42255437 | PubTator, text mining | PubMed |
| Multi-dimensional profiling of lactylation-related signatures for prognostic and therapeutic insights in bladder cancer. | Cancer Cell Int | 2026 | 42251369 | PubTator, text mining | PubMed |
| Comprehensive Clinicopathologic and Molecular Analysis of Mesenchymal Tumors With BRAF Fusions. | Genes Chromosomes Cancer | 2026 | 42192570 | PubTator, text mining | PubMed |
| Tumour location and mismatch repair status impact gene expression profiles associated with lymph node metastases in T1 colon cancers. | Sci Rep | 2026 | 42135430 | PubTator, text mining | PubMed |
| Mechanistic Insights Into OSM and IL-31 in Primary Localized Cutaneous Amyloidosis: A Narrative Review. | Int J Dermatol | 2026 | 42029085 | PubTator, text mining | PubMed |
| Histochemical characterization of muscularis macrophage loss and disruption of a miR-93-5p-AHNAK neuro-immune axis in Hirschsprung's disease. | Histochem Cell Biol | 2026 | 41933096 | PubTator, text mining | PubMed |
1 to 10 of 1,483
See all 1,483 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/79026
GET https://conductscience.org/api/genes/v1/79026/patents?page=2